New blood test could replace liver biopsies for silent liver disease
NCT ID NCT07502755
Summary
This study aims to see if a new blood test can accurately diagnose and track a serious liver disease called NASH, which is linked to obesity and type 2 diabetes. Researchers will test the blood of 828 people to see if measuring two specific markers (PLIN2 and RAB14) in white blood cells works as well as or better than current scans and scores. The goal is to find a simpler, non-invasive way to identify and monitor this condition without needing a liver biopsy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Roma, 00168, Italy
Conditions
Explore the condition pages connected to this study.